SOLVAY S.A. A/ BE0003470755 /
2024-03-28 10:59:14 PM | Chg. +0.120 | Volume | Bid10:59:14 PM | Ask10:59:14 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
25.040EUR | +0.48% | - Turnover: - |
25.040Bid Size: - | 25.330Ask Size: - | 2.62 bill.EUR | 16.01% | 1.38 |
GlobeNewswire
2023-10-25
NobleAI Announces Groundbreaking Collaboration with Microsoft Azure Quantum Elements
GlobeNewswire
2023-10-12
NobleAI’s Science-Based AI Technology to be Highlighted at SPE Annual Technical Conference and Expos...
GlobeNewswire
2023-10-07
CERN Inaugurates Science Gateway, Its New Outreach Centre for Science Education
GlobeNewswire
2023-09-19
Radix Engineering Expands US Operations, Appoints Alexander Clausbruch North America CEO
GlobeNewswire
2023-09-07
NobleAI Launches New AI-Powered Chemical and Materials Informatics Solutions on Microsoft’s Azure Ma...
GlobeNewswire
2022-02-17
Bluebell Capital Partners - Response to Solvay Board Open Letter Regarding Soda Ash Operations in Ro...
GlobeNewswire
2022-01-11
Western Rare Earths Announced as Team Member of the US Critical Materials Institute; Partner to DOE ...
GlobeNewswire
2021-03-29
Solvay’s Kadri will Present Keynote Lecture at AIChE’s Virtual Spring Meeting & Global Congress on P...
GlobeNewswire
2020-10-01
Intra-Cellular Therapies Announces the Appointment of Dr. Suresh Durgam as Chief Medical Officer